Clinical trial
Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In…
NCT00290394 · Baskent University, Other · Completed
Key facts
| NCT number | NCT00290394 |
|---|---|
| Title | Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients |
| Official title | Study of PPAR Gamma Agonist-Rosiglitazone in Normotensive Type 2 Diabetics With Ambulatory Blood Pressure Monitoring |
| Lead sponsor | Baskent University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | rosiglitazone(drug), blood pressure lowering effect |
| Enrollment | 25 |
| Start date | Mar 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Feb 13, 2006 |
| Last update posted | Feb 13, 2006 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: